The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Single Session Combined Locoregional Therapies for Hepatocellular Carcinoma
Official Title: Comparison of Single Session Transarterial Chemoembolization Combined With Microwave Ablation or Radiofrequency Ablation in Treatment of Hepatocellular Carcinoma: A Randomized Controlled Study
Study ID: NCT02646137
Brief Summary: Hepatocellular carcinoma is the third most common cause of cancer-related mortality. In recent years, transarterial chemoembolization, radio frequency ablation and microwave ablation have been accepted as treatment modalities for patients with surgically unresectable hepatocellular carcinoma.
Detailed Description: To compare between combination treatment with radiofrequency or microwave ablation followed by transarterial chemoembolization and performed in a single session.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Tanta university hospital, Tanta, , Egypt
Name: Elshazly Sheta, Professor
Affiliation: Hepatology and gastroenterology dept.-Tanta
Role: PRINCIPAL_INVESTIGATOR
Name: Ferial El-kalla, Professor
Affiliation: Division of Gastroenterology and Hepatology- Tanta
Role: PRINCIPAL_INVESTIGATOR
Name: Mohamed Elgharib, Professor
Affiliation: Interventional radiology - Ainshams university- Egypt
Role: STUDY_DIRECTOR
Name: Abdelrahman kobtan, Consultant
Affiliation: liver diseases dept.-Tanta university hospital
Role: STUDY_CHAIR
Name: Mohamed Elhendawy, Consultant
Affiliation: liver diseases dept.-Tanta university hospital
Role: STUDY_CHAIR
Name: Sherief Abd-Elsalam, Consultant
Affiliation: Hepatology and gastroenterology dept.-Tanta
Role: STUDY_CHAIR
Name: Ibrahim Amer, Consultant
Affiliation: Liver diseases and gastroenterology dept.-Tanta university hospital
Role: STUDY_CHAIR